Patent · US Active

Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma

US8388972B2 · kind B2 · utility

2Cited by
0References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 12, 2007
Grant dateMar 5, 2013
Priority date
Expiry dateMay 1, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Antibody or fragment thereof, which specifically binds to folate receptor-alpha (FRα), wherein said antibody or fragment thereof comprises a light chain whose variable region comprises at least one of the following amino acid sequences: —RASESVSFLGINLIH (SEQ ID NO: 3), —QASNKDT (SEQ ID NO: 4), —LQSKNFPPYT (SEQ ID NO: 5), and wherein the constant region of said light chain is a kappa constant region.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.